FOXO1
FOXO1 (Forkhead Box O1) is a protein that in humans is encoded by the FOXO1 gene. It is a member of the Forkhead box family of transcription factors, characterized by a distinct forkhead domain. This protein likely functions as a trigger for apoptosis through expression of genes necessary for cell death. Tumor suppression, regulation of the insulin signaling pathway, and longevity are also associated with this protein.
Function[edit | edit source]
FOXO1 is a key regulator of glucose homeostasis, cellular antioxidant defense system, and cell cycle regulation. It is involved in the insulin signaling pathway and can shut down genes that produce glucose. In the absence of insulin, FOXO1 promotes glucose production by the liver to prevent low blood sugar. When insulin is present, it inhibits FOXO1, reducing glucose production.
Clinical significance[edit | edit source]
Alterations in the function of FOXO1 have been associated with several cancer types, including breast cancer, prostate cancer, and leukemia. It has also been implicated in diabetes, as it plays a crucial role in regulating insulin sensitivity.
In cancer, FOXO1 acts as a tumor suppressor. It can promote cell cycle arrest and apoptosis, preventing the uncontrolled cell growth characteristic of cancer. However, in some cancers, FOXO1 is inactivated, leading to unchecked cell proliferation.
In diabetes, the role of FOXO1 is complex. On one hand, it can increase glucose production, contributing to high blood sugar levels. On the other hand, it can improve insulin sensitivity, helping to lower blood sugar. Therefore, understanding and manipulating the activity of FOXO1 could potentially lead to new treatments for diabetes.
Research[edit | edit source]
Research into the function and regulation of FOXO1 is ongoing. Current studies are focused on understanding how FOXO1 activity is controlled and how it interacts with other proteins and pathways in the cell. This research could lead to new strategies for treating diseases associated with FOXO1, such as cancer and diabetes.
See also[edit | edit source]
 | This genetics article is a stub. You can help WikiMD by expanding it. |
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
